1. Home
  2. WLDN vs AVDL Comparison

WLDN vs AVDL Comparison

Compare WLDN & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Willdan Group Inc.

WLDN

Willdan Group Inc.

HOLD

Current Price

$128.33

Market Cap

2.0B

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.54

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLDN
AVDL
Founded
1964
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
WLDN
AVDL
Price
$128.33
$21.54
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
$123.25
$19.14
AVG Volume (30 Days)
300.0K
1.5M
Earning Date
03-05-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
71.17
N/A
EPS
2.79
N/A
Revenue
$651,926,000.00
$248,517,000.00
Revenue This Year
N/A
$65.47
Revenue Next Year
$9.90
$30.88
P/E Ratio
$47.16
N/A
Revenue Growth
12.90
79.88
52 Week Low
$30.43
$6.38
52 Week High
$135.10
$23.57

Technical Indicators

Market Signals
Indicator
WLDN
AVDL
Relative Strength Index (RSI) 62.25 59.15
Support Level $125.04 $21.45
Resistance Level $135.10 $21.56
Average True Range (ATR) 5.87 0.07
MACD 0.63 -0.03
Stochastic Oscillator 73.72 68.29

Price Performance

Historical Comparison
WLDN
AVDL

About WLDN Willdan Group Inc.

Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: